Publication Results

Generate Report

Add publications by marking their checkboxes, or

Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial.

Ryan Wolf J,  Gewandter JS,  Bautista J,  Heckler CE,  Strasser J,  Dyk P,  Anderson T,  Gross H,  Speer T,  Dolohanty L,  Bylund K,  Pentland AP,  Morrow GR
Support Care Cancer 2020 Jul;28(7):3303-3311
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31758326
PMC ID: PMC7242117

NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.

Lee EQ,  Zhang P,  Wen PY,  Gerstner ER,  Reardon DA,  Aldape KD,  deGroot JF,  Pan E,  Raizer JJ,  Kim LJ,  Chmura SJ,  Robins HI,  Connelly JM,  Battiste JD,  Villano JL,  Wagle N,  Merrell RT,  Wendland MM,  Mehta MP
Cancer 2020 Jun 15;126(12):2821-2828
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32154928
PMC ID: PMC7245544 [available on June 15, 2021]

Querying Patients With Cancer About Sexual Health and Sexual and Gender Minority Status: A Qualitative Study of Health-Care Providers.

Cathcart-Rake E,  O'Connor JM,  Ridgeway JL,  Breitkopf CR,  Guire LJM,  Olson EA,  Kaur JS,  Leventakos K,  Jatoi A
Am J Hosp Palliat Care 2020 Jun;37(6):418-423
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31601116
PMC ID: PMC7145741

Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.

Gewandter JS,  Kleckner AS,  Marshall JH,  Brown JS,  Curtis LH,  Bautista J,  Dworkin RH,  Kleckner IR,  Kolb N,  Mohile SG,  Mustian KM
Support Care Cancer 2020 Jun;28(6):2553-2562
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31494735
PMC ID: PMC7060096 [available on June 01, 2021]

Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials.

Hershman DL,  Till C,  Wright JD,  Accordino M,  Vaidya R,  Barlow WE,  Ramsey S,  Unger JM
Breast Cancer Res Treat 2020 Jun;181(2):455-463
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32306168
PMC ID: not available

Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial.

Torkko K,  Till C,  Tangen CM,  Goodman PJ,  Song X,  Schenk JM,  Lucia MS,  Peters U,  van Bokhoven A,  Thompson IM,  Neuhouser ML
Cancer Prev Res (Phila) 2020 Jun;13(6):521-530
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32102946
PMC ID: PMC7272271 [available on December 01, 2020]

Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study.

Yeung AR,  Pugh SL,  Klopp AH,  Gil KM,  Wenzel L,  Westin SN,  Gaffney DK,  Small W Jr,  Thompson S,  Doncals DE,  Cantuaria GHC,  Yaremko BP,  Chang A,  Kundapur V,  Mohan DS,  Haas ML,  Kim YB,  Ferguson CL,  Deshmukh S,  Bruner DW,  Kachnic LA
J Clin Oncol 2020 May 20;38(15):1685-1692
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32073955
PMC ID: PMC7238486 [available on May 20, 2021]

How (and why) to ask the older cancer patient about sexual health and sexual minority status.

Cathcart-Rake E,  O'Connor JM,  Jacobson A,  McGuire L,  Jatoi A
J Geriatr Oncol 2020 May;11(4):576-578
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31447290
PMC ID: PMC7035152 [available on May 01, 2021]

Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204).

Chakravarthy AB,  Zhao F,  Meropol NJ,  Flynn PJ,  Wagner LI,  Sloan J,  Diasio RB,  Mitchell EP,  Catalano P,  Giantonio BJ,  Catalano RB,  Haller DG,  Awan RA,  Mulcahy MF,  O'Brien TE,  Santala R,  Cripps C,  Weis JR,  Atkins JN,  Leichman CG,  Petrelli NJ,  Sinicrope FA,  Brierley JD,  Tepper JE,  O'Dwyer PJ,  Sigurdson ER,  Hamilton SR,  Cella D,  Benson AB 3rd
Oncologist 2020 May;25(5):e798-e807
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31852811
PMC ID: PMC7216434

Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study.

Chase D,  Huang HQ,  Monk BJ,  Ramondetta LM,  Penson RT,  Gil K,  Landrum LM,  Leitao M,  Oaknin A,  Huh WK,  Pulaski HL,  Robison K,  Guntupalli SR,  Richardson D,  Salani R,  Sill MW,  Wenzel LB,  Tewari KS
Int J Gynecol Cancer 2020 May;30(5):596-601
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32114513
PMC ID: not available

A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances: NCCTG N07C4 (Alliance).

Barton DL,  Atherton PJ,  Satele DV,  Qin R,  Dakhil S,  Pipe T,  Hobday T,  Fee-Schroeder K,  Loprinzi CL
Support Care Cancer 2020 Apr 19
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32307658
PMC ID: not available

Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes.

Le-Rademacher JG,  Lopez CL,  Kanwar R,  Major-Elechi B,  Abyzov A,  Banck MS,  Therneau TM,  Sloan JA,  Loprinzi CL,  Beutler AS
J Neurol Sci 2020 Apr 15;411:116687
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32018185
PMC ID: PMC7096263

Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424.

Fisher BJ,  Pugh SL,  Macdonald DR,  Chakravatri A,  Lesser GJ,  Fox S,  Rogers CL,  Werner-Wasik M,  Doyle T,  Bahary JP,  Fiveash JB,  Bovi JA,  Howard SP,  Michael Yu HH,  D'Souza D,  Laack NN,  Barani IJ,  Kwok Y,  Wahl DR,  Strasser JF,  Won M,  Mehta MP
Int J Radiat Oncol Biol Phys 2020 Apr 3
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32251755
PMC ID: not available

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.

Brown PD,  Gondi V,  Pugh S,  Tome WA,  Wefel JS,  Armstrong TS,  Bovi JA,  Robinson C,  Konski A,  Khuntia D,  Grosshans D,  Benzinger TLS,  Bruner D,  Gilbert MR,  Roberge D,  Kundapur V,  Devisetty K,  Shah S,  Usuki K,  Anderson BM,  Stea B,  Yoon H,  Li J,  Laack NN,  Kruser TJ,  Chmura SJ,  Shi W,  Deshmukh S,  Mehta MP,  Kachnic LA,  for NRG Oncology
J Clin Oncol 2020 Apr 1;38(10):1019-1029
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32058845
PMC ID: PMC7106984 [available on April 01, 2021]

Racial/Ethnic Differences in Comprehension of Biospecimen Collection: a Nationwide University of Rochester Cancer Center NCI Community Oncology Research Program Study.

Asare M,  Heckler CE,  Culakova E,  Kamen CS,  Kleckner AS,  Minasian LM,  Wendler DS,  Feige M,  Weil CJ,  Long J,  Cole SK,  Onitilo AA,  Peppone LJ,  Morrow GR,  Janelsins MC
J Cancer Educ 2020 Apr;35(2):292-300
Major Program(s) or Research Group(s): NCI Community Oncology Research Program ;  Office of the Director
PubMed ID: 30612315
PMC ID: PMC6612536

Psychometric development of a new body image scale for breast cancer survivors.

Biederman E,  Cohee A,  Monahan P,  Stump T,  Champion V
Health Care Women Int 2020 Apr;41(4):397-411
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31237491
PMC ID: PMC6930352 [available on April 01, 2021]

Associations of inflammation with frailty in patients with breast cancer aged 50 and over receiving chemotherapy.

Gilmore N,  Kadambi S,  Lei L,  Loh KP,  Mohamed M,  Magnuson A,  Cole S,  Esparaz BT,  Giguere JK,  Mohile S,  Janelsins M
J Geriatr Oncol 2020 Apr;11(3):423-430
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30992181
PMC ID: PMC6790284

More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer.

Roeland EJ,  Sera CJ,  Ma JD
Support Care Cancer 2020 Apr;28(4):1793-1797
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31332514
PMC ID: not available

Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218.

Alvarez Secord A,  Bell Burdett K,  Owzar K,  Tritchler D,  Sibley AB,  Liu Y,  Starr MD,  Brady JC,  Lankes HA,  Hurwitz HI,  Mannel RS,  Tewari KS,  O'Malley DM,  Gray H,  Bakkum-Gamez JN,  Fujiwara K,  Boente M,  Deng W,  Burger RA,  Birrer MJ,  Nixon AB
Clin Cancer Res 2020 Mar 15;26(6):1288-1296
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31919136
PMC ID: PMC7073274 [available on September 15, 2020]

Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221).

Ambrosone CB,  Zirpoli GR,  Hutson AD,  McCann WE,  McCann SE,  Barlow WE,  Kelly KM,  Cannioto R,  Sucheston-Campbell LE,  Hershman DL,  Unger JM,  Moore HCF,  Stewart JA,  Isaacs C,  Hobday TJ,  Salim M,  Hortobagyi GN,  Gralow JR,  Budd GT,  Albain KS
J Clin Oncol 2020 Mar 10;38(8):804-814
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31855498
PMC ID: PMC7062457 [available on March 10, 2021]

A cohort study of quality of life in partners of young breast cancer survivors compared to partners of healthy controls.

Cohee A,  Storey S,  Winger JG,  Cella D,  Stump T,  Monahan PO,  Champion VL
J Patient Rep Outcomes 2020 Mar 6;4(1):19
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32144626
PMC ID: PMC7060298

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.

Bradley JD,  Hu C,  Komaki RR,  Masters GA,  Blumenschein GR,  Schild SE,  Bogart JA,  Forster KM,  Magliocco AM,  Kavadi VS,  Narayan S,  Iyengar P,  Robinson CG,  Wynn RB,  Koprowski CD,  Olson MR,  Meng J,  Paulus R,  Curran WJ Jr,  Choy H
J Clin Oncol 2020 Mar 1;38(7):706-714
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31841363
PMC ID: PMC7048161 [available on March 01, 2021]

Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.

Abrams RA,  Winter KA,  Safran H,  Goodman KA,  Regine WF,  Berger AC,  Gillin MT,  Philip PA,  Lowy AM,  Wu A,  DiPetrillo TA,  Corn BW,  Seaward SA,  Haddock MG,  Song S,  Jiang Y,  Fisher BJ,  Katz AW,  Mehta S,  Willett CG,  Crane CH
Am J Clin Oncol 2020 Mar;43(3):173-179
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31985516
PMC ID: PMC7280743 [available on March 01, 2021]

Longitudinal assessment of the impact of higher body mass index on cancer-related fatigue in patients with breast cancer receiving chemotherapy.

Inglis JE,  Janelsins MC,  Culakova E,  Mustian KM,  Lin PJ,  Kleckner IR,  Peppone LJ
Support Care Cancer 2020 Mar;28(3):1411-1418
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31267279
PMC ID: PMC7243469

Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.

Reyngold M,  Winter KA,  Regine WF,  Abrams RA,  Safran H,  Hoffman JP,  Mowat RB,  Hayes JP,  Kessel IL,  DiPetrillo T,  Narayan S,  Chen Y,  Ben-Josef E,  Delouya G,  Suh JH,  Meyer J,  Haddock MG,  Feldman M,  Gaur R,  Yost K,  Peterson RA,  Sherr DL,  Moughan J,  Crane CH
Oncologist 2020 Mar;25(3):e477-e483
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32162826
PMC ID: PMC7066692

Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.

Roth ME,  Unger JM,  O'Mara AM,  Lewis MA,  Budd T,  Johnson RH,  Pollock BH,  Blanke C,  Freyer DR
Cancer Med 2020 Mar;9(6):2146-2152
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32009305
PMC ID: PMC7064039

Geriatric oncology health services research: Cancer and Aging Research Group infrastructure core.

Wong ML,  Lichtman SM,  Morrow GR,  Simmons J,  Hargraves T,  Gross CP,  Lund JL,  Lowenstein LM,  Walter LC,  McDermott CL,  Mohile SG,  Cohen HJ
J Geriatr Oncol 2020 Mar;11(2):350-354
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31326392
PMC ID: PMC6980419 [available on January 17, 2021]

Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.

Comstock CE,  Gatsonis C,  Newstead GM,  Snyder BS,  Gareen IF,  Bergin JT,  Rahbar H,  Sung JS,  Jacobs C,  Harvey JA,  Nicholson MH,  Ward RC,  Holt J,  Prather A,  Miller KD,  Schnall MD,  Kuhl CK
JAMA 2020 Feb 25;323(8):746-756
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 32096852
PMC ID: PMC7276668

NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.

Fehrenbacher L,  Cecchini RS,  Geyer CE Jr,  Rastogi P,  Costantino JP,  Atkins JN,  Crown JP,  Polikoff J,  Boileau JF,  Provencher L,  Stokoe C,  Moore TD,  Robidoux A,  Flynn PJ,  Borges VF,  Albain KS,  Swain SM,  Paik S,  Mamounas EP,  Wolmark N
J Clin Oncol 2020 Feb 10;38(5):444-453
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31821109
PMC ID: PMC7007289 [available on February 10, 2021]

Meta-analysis of 16 studies of the association of alcohol with colorectal cancer.

McNabb S,  Harrison TA,  Albanes D,  Berndt SI,  Brenner H,  Caan BJ,  Campbell PT,  Cao Y,  Chang-Claude J,  Chan A,  Chen Z,  English DR,  Giles GG,  Giovannucci EL,  Goodman PJ,  Hayes RB,  Hoffmeister M,  Jacobs EJ,  Joshi AD,  Larsson SC,  Le Marchand L,  Li L,  Lin Y,  Männistö S,  Milne RL,  Nan H,  Newton CC,  Ogino S,  Parfrey PS,  Petersen PS,  Potter JD,  Schoen RE,  Slattery ML,  Su YR,  Tangen CM,  Tucker TC,  Weinstein SJ,  White E,  Wolk A,  Woods MO,  Phipps AI,  Peters U
Int J Cancer 2020 Feb 1;146(3):861-873
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 31037736
PMC ID: PMC6819207 [available on February 01, 2021]

Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3).

Trifiletti DM,  Ballman KV,  Brown PD,  Anderson SK,  Carrero XW,  Cerhan JH,  Whitton AC,  Greenspoon J,  Parney IF,  Laack NN,  Ashman JB,  Bahary JP,  Hadjipanayis CG,  Urbanic JJ,  Barker FG 2nd,  Farace E,  Khuntia D,  Giannini C,  Buckner JC,  Galanis E,  Roberge D
Int J Radiat Oncol Biol Phys 2020 Feb 1;106(2):255-260
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31654784
PMC ID: PMC6957747 [available on February 01, 2021]

GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients.

Carlson JW,  Kauderer J,  Hutson A,  Carter J,  Armer J,  Lockwood S,  Nolte S,  Stewart BR,  Wenzel L,  Walker J,  Fleury A,  Bonebrake A,  Soper J,  Mathews C,  Zivanovic O,  Richards WE,  Tan A,  Alberts DS,  Barakat RR
Gynecol Oncol 2020 Feb;156(2):467-474
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31837831
PMC ID: PMC7018616 [available on February 01, 2021]

Complications and Survivorship Trends After Primary Debulking Surgery for Ovarian Cancer.

Xu Z,  Becerra AZ,  Justiniano CF,  Aquina CT,  Fleming FJ,  Boscoe FP,  Schymura MJ,  Sinno AK,  Chaoul J,  Morrow GR,  Minasian L,  Temkin SM
J Surg Res 2020 Feb;246:34-41
Major Program(s) or Research Group(s): NCI Community Oncology Research Program ;  Office of the Director
PubMed ID: 31561176
PMC ID: PMC6917987 [available on February 01, 2021]

Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial.

Parsons JK,  Zahrieh D,  Mohler JL,  Paskett E,  Hansel DE,  Kibel AS,  Liu H,  Seisler DK,  Natarajan L,  White M,  Hahn O,  Taylor J,  Hartman SJ,  Stroup SP,  Van Veldhuizen P,  Hall L,  Small EJ,  Morris MJ,  Pierce JP,  Marshall J
JAMA 2020 Jan 14;323(2):140-148
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31935026
PMC ID: PMC6990696 [available on July 14, 2020]

A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer.

Zhong J,  Jermusyk A,  Wu L,  Hoskins JW,  Collins I,  Mocci E,  Zhang M,  Song L,  Chung CC,  Zhang T,  Xiao W,  Albanes D,  Andreotti G,  Arslan AA,  Babic A,  Bamlet WR,  Beane-Freeman L,  Berndt S,  Borgida A,  Bracci PM,  Brais L,  Brennan P,  Bueno-de-Mesquita B,  Buring J,  Canzian F,  Childs EJ,  Cotterchio M,  Du M,  Duell EJ,  Fuchs C,  Gallinger S,  Gaziano JM,  Giles GG,  Giovannucci E,  Goggins M,  Goodman GE,  Goodman PJ,  Haiman C,  Hartge P,  Hasan M,  Helzlsouer KJ,  Holly EA,  Klein EA,  Kogevinas M,  Kurtz RJ,  LeMarchand L,  Malats N,  Männistö S,  Milne R,  Neale RE,  Ng K,  Obazee O,  Oberg AL,  Orlow I,  Patel AV,  Peters U,  Porta M,  Rothman N,  Scelo G,  Sesso HD,  Severi G,  Sieri S,  Silverman D,  Sund M,  Tjønneland A,  Thornquist MD,  Tobias GS,  Trichopoulou A,  Van Den Eeden SK,  Visvanathan K,  Wactawski-Wende J,  Wentzensen N,  White E,  Yu H,  Yuan C,  Zeleniuch-Jacquotte A,  Hoover R,  Brown K,  Kooperberg C,  Risch HA,  Jacobs EJ,  Li D,  Yu K,  Shu XO,  Chanock SJ,  Wolpin BM,  Stolzenberg-Solomon RZ,  Chatterjee N,  Klein AP,  Smith JP,  Kraft P,  Shi J,  Petersen GM,  Zheng W,  Amundadottir LT
J Natl Cancer Inst 2020 Jan 9
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 31917448
PMC ID: not available

A pooled analysis of the cardiac events in the trastuzumab adjuvant trials.

de Azambuja E,  Ponde N,  Procter M,  Rastogi P,  Cecchini RS,  Lambertini M,  Ballman K,  Aspitia AM,  Zardavas D,  Roca L,  Gelber RD,  Piccart-Gebhart M,  Suter T
Breast Cancer Res Treat 2020 Jan;179(1):161-171
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31605311
PMC ID: PMC6989393 [available on January 01, 2021]

Intellectual Equipoise and Challenges: Accruing Patients With Advanced Cancer to a Trial Randomizing to Surgical or Nonsurgical Management (SWOG S1316).

Deutsch GB,  Deneve JL,  Al-Kasspooles MF,  Nfonsam VN,  Gunderson CC,  Secord AA,  Rodgers P,  Hendren S,  Silberfein EJ,  Grant M,  Sloan J,  Sun V,  Arnold KB,  Anderson GL,  Krouse RS
Am J Hosp Palliat Care 2020 Jan;37(1):12-18
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31122027
PMC ID: PMC6868288 [available on January 01, 2021]

Attitudes of Clinicians about Screening Head and Neck Cancer Survivors for Lung Cancer Using Low-Dose Computed Tomography.

Dukes K,  Seaman AT,  Hoffman RM,  Christensen AJ,  Kendell N,  Sussman AL,  Vélez-Bermúdez M,  Volk RJ,  Pagedar NA
Ann Otol Rhinol Laryngol 2020 Jan;129(1):23-31
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31409114
PMC ID: PMC6945809

Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance).

Klepin HD,  Ritchie E,  Major-Elechi B,  Le-Rademacher J,  Seisler D,  Storrick L,  Sanford BL,  Marcucci G,  Zhao W,  Geyer SA,  Ballman KV,  Powell BL,  Baer MR,  Stock W,  Cohen HJ,  Stone RM,  Larson RA,  Uy GL
J Geriatr Oncol 2020 Jan;11(1):107-113
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31668825
PMC ID: PMC6943189 [available on January 01, 2021]

Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study.

Mai PL,  Huang HQ,  Wenzel LB,  Han PK,  Moser RP,  Rodriguez GC,  Boggess J,  Rutherford TJ,  Cohn DE,  Kauff ND,  Phillips KA,  Wilkinson K,  Wenham RM,  Hamilton C,  Powell MA,  Walker JL,  Greene MH,  Hensley ML
Gynecol Oncol 2020 Jan;156(1):131-139
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31759774
PMC ID: PMC6980744 [available on January 01, 2021]

Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.

Vicini FA,  Cecchini RS,  White JR,  Arthur DW,  Julian TB,  Rabinovitch RA,  Kuske RR,  Ganz PA,  Parda DS,  Scheier MF,  Winter KA,  Paik S,  Kuerer HM,  Vallow LA,  Pierce LJ,  Mamounas EP,  McCormick B,  Costantino JP,  Bear HD,  Germain I,  Gustafson G,  Grossheim L,  Petersen IA,  Hudes RS,  Curran WJ Jr,  Bryant JL,  Wolmark N
Lancet 2019 Dec 14;394(10215):2155-2164
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31813636
PMC ID: PMC7199428 [available on December 14, 2020]

Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31.

Chumsri S,  Li Z,  Serie DJ,  Mashadi-Hossein A,  Colon-Otero G,  Song N,  Pogue-Geile KL,  Gavin PG,  Paik S,  Moreno-Aspitia A,  Perez EA,  Thompson EA
J Clin Oncol 2019 Dec 10;37(35):3425-3435
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31622131
PMC ID: PMC6900835 [available on December 10, 2020]

Engaging older patients with cancer and their caregivers as partners in cancer research.

Gilmore NJ,  Canin B,  Whitehead M,  Sedenquist M,  Griggs L,  Finch L,  Grossman V,  Targia V,  Wells M,  Kamen C,  Flannery M,  Magnuson A,  Plumb S,  Obrecht S,  Lowenstein LM,  Lopez G,  Anderson J,  Berenberg J,  Vogel V,  Bearden J,  Dale W,  Mohile SG
Cancer 2019 Dec 1;125(23):4124-4133
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31420878
PMC ID: PMC6856383 [available on December 01, 2020]

Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance).

Al-Refaie WB,  Decker PA,  Ballman KV,  Pisters PWT,  Posner MC,  Hunt KK,  Meyers B,  Weinberg AD,  Nelson H,  Newman L,  Tan A,  Le-Rademacher JG,  Hurria A,  Jatoi A
Ann Surg Oncol 2019 Dec;26(13):4213-4221
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31605327
PMC ID: PMC6868343 [available on December 01, 2020]

GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE).

Carter J,  Huang HQ,  Armer J,  Carlson JW,  Lockwood S,  Nolte S,  Stewart BR,  Kauderer J,  Hutson A,  Walker JL,  Fleury AC,  Bonebrake A,  Soper JT,  Mathews C,  Zivanovic O,  Richards WE,  Tan A,  Alberts DS,  Barakat RR,  Wenzel L
Gynecol Oncol 2019 Dec;155(3):452-460
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31679787
PMC ID: PMC6900449 [available on December 01, 2020]

Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902.

Hamstra DA,  Pugh SL,  Lepor H,  Rosenthal SA,  Pienta KJ,  Gomella L,  Peters C,  D'Souza DP,  Zeitzer KL,  Jones CU,  Hall WA,  Horwitz E,  Pisansky TM,  Souhami L,  Hartford AC,  Dominello M,  Feng F,  Sandler HM
Radiother Oncol 2019 Dec;141:137-143
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31540746
PMC ID: PMC6912855 [available on December 01, 2020]

Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial.

Kleckner IR,  Kamen C,  Cole C,  Fung C,  Heckler CE,  Guido JJ,  Culakova E,  Onitilo AA,  Conlin A,  Kuebler JP,  Mohile S,  Janelsins M,  Mustian KM
Support Care Cancer 2019 Dec;27(12):4615-4625
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30937600
PMC ID: PMC6774911 [available on December 01, 2020]

A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study.

O'Cearbhaill RE,  Deng W,  Chen LM,  Lucci JA 3rd,  Behbakht K,  Spirtos NM,  Muller CY,  Benigno BB,  Powell MA,  Berry E,  Tewari KS,  Hanjani P,  Lankes HA,  Aghajanian C,  Sabbatini PJ
Gynecol Oncol 2019 Dec;155(3):393-399
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31653510
PMC ID: PMC6900458 [available on December 01, 2020]

Positive effects of acupressure bands combined with relaxation music/instructions on patients most at risk for chemotherapy-induced nausea.

Peoples AR,  Culakova E,  Heckler CE,  Shayne M,  O'Connor TL,  Kirshner JJ,  Bushunow PW,  Morrow GR,  Roscoe JA
Support Care Cancer 2019 Dec;27(12):4597-4605
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 30929028
PMC ID: PMC6768770 [available on December 01, 2020]

Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMI.

Tangen CM,  Schenk J,  Till C,  Goodman PJ,  Barrington W,  Lucia MS,  Thompson IM
Cancer Epidemiol 2019 Dec;63:101619
Major Program(s) or Research Group(s): NCI Community Oncology Research Program
PubMed ID: 31639607
PMC ID: PMC6938232 [available on December 01, 2020]